Menu
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

1.690%
0.4
1.690%
-
 
08:05 / Frankfurt WKN: A40BDL / Name: Curatis Holding / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for Curatis Holding

sharewise wants to provide you with the best news and tools for Curatis Holding, so we directly link to the best financial data sources.

News

Curatis: Double-digit revenue growth in 2025
and major milestones for corticorelin achieved
Curatis: Double-digit revenue growth in 2025 and major milestones for corticorelin achieved
Curatis: Double-digit revenue growth in 2025 and major milestones for corticorelin achieved
Curatis and Neupharma announce exclusive licensing
agreement to develop and market corticorelin (C-PTBE-01)
for the treatment of peritumoral brain edema in Japan
Curatis and Neupharma announce exclusive licensing agreement to develop and market corticorelin (C-PTBE-01) for the treatment of peritumoral brain edema in Japan
Curatis and Neupharma announce exclusive licensing agreement to develop and market corticorelin (C-PTBE-01) for the treatment of peritumoral brain edema in Japan
Curatis Holding AG announces CHF 1.2 million private placement with strategic investor
Curatis Holding AG announces CHF 1.2 million private placement with strategic investor
Curatis Holding AG announces CHF 1.2 million private placement with strategic investor